Categories AlphaGraphs, Earnings, Health Care
ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020.
Net earnings for the fourth quarter was $2.16 billion, or $1.20 per share, compared to net earnings of $1.04 billion, or $0.59 per share in the fourth quarter of 2019.
Total net sales increased 28.7% to $10.7 billion.
Abbott shares inched up 1% during the pre-market hours following the earnings announcement.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
